Peter DeLong

968 total citations
20 papers, 770 citations indexed

About

Peter DeLong is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Peter DeLong has authored 20 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Peter DeLong's work include Occupational and environmental lung diseases (4 papers), Virus-based gene therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Peter DeLong is often cited by papers focused on Occupational and environmental lung diseases (4 papers), Virus-based gene therapy research (3 papers) and Immune Cell Function and Interaction (3 papers). Peter DeLong collaborates with scholars based in United States, India and Lebanon. Peter DeLong's co-authors include Steven Μ. Albelda, Tomoyuki Tanaka, Larry R. Kaiser, Veena Kapoor, Daniel H. Sterman, Adam C. Henry, Larry R. Kaiser, Mamoru Watanabe, Leslie A. Litzky and Robert Kruklitis and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Virology.

In The Last Decade

Peter DeLong

20 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter DeLong United States 14 256 247 213 203 123 20 770
J. J. Rinehart United States 13 113 0.4× 193 0.8× 268 1.3× 154 0.8× 88 0.7× 28 650
Sherry T. Shu United States 18 113 0.4× 233 0.9× 153 0.7× 342 1.7× 65 0.5× 34 743
Miriam Corti United States 11 170 0.7× 55 0.2× 116 0.5× 251 1.2× 49 0.4× 15 550
Kohei Tada Japan 15 42 0.2× 242 1.0× 158 0.7× 220 1.1× 51 0.4× 33 594
Nobuyuki Uchida Japan 13 206 0.8× 84 0.3× 72 0.3× 177 0.9× 86 0.7× 47 709
Aaron R. Ellison United States 14 79 0.3× 111 0.4× 257 1.2× 287 1.4× 164 1.3× 27 1.1k
Sonja Thaler Germany 14 47 0.2× 162 0.7× 103 0.5× 274 1.3× 73 0.6× 25 542
Leal Oburoglu Sweden 11 31 0.1× 108 0.4× 418 2.0× 330 1.6× 88 0.7× 16 834
Yonghua Zhuang United States 17 150 0.6× 100 0.4× 206 1.0× 201 1.0× 38 0.3× 33 724
Douglas J. Dorahy Australia 17 137 0.5× 144 0.6× 173 0.8× 325 1.6× 189 1.5× 21 911

Countries citing papers authored by Peter DeLong

Since Specialization
Citations

This map shows the geographic impact of Peter DeLong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter DeLong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter DeLong more than expected).

Fields of papers citing papers by Peter DeLong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter DeLong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter DeLong. The network helps show where Peter DeLong may publish in the future.

Co-authorship network of co-authors of Peter DeLong

This figure shows the co-authorship network connecting the top 25 collaborators of Peter DeLong. A scholar is included among the top collaborators of Peter DeLong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter DeLong. Peter DeLong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DeLong, Peter, et al.. (2021). A case of tracheal and pulmonary blastomycosis presenting as asymptomatic pulmonary nodules. Medical Mycology Case Reports. 34. 1–4. 1 indexed citations
2.
3.
Marotti, Jonathan D., Nancy J. McNulty, James R. Rigas, et al.. (2011). Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: A retrospective review of 50 cases. Diagnostic Cytopathology. 41(1). 15–21. 14 indexed citations
4.
Dragnev, Konstantin H., Peter DeLong, Lisa Tilluckdharry, et al.. (2011). KRAS and EGFR Results From EBUS Evaluation of Mediastinal Adenopathy. CHEST Journal. 140(4). 939A–939A. 11 indexed citations
5.
Black, Candice C., Mary Jo Turk, Peter DeLong, et al.. (2007). P1-160: Patterns of FoxP3 expression in tumor infiltrating lymphocytes. Journal of Thoracic Oncology. 2(8). S799–S799. 1 indexed citations
6.
DeLong, Peter, James Murray, & Christopher K. Cook. (2006). CRITICAL CARE ISSUES FOR THE NEPHROLOGIST: Mechanical Ventilation in the Management of Acute Respiratory Distress Syndrome. Seminars in Dialysis. 19(6). 517–524. 18 indexed citations
7.
DeLong, Peter, Richard G. Carroll, Adam C. Henry, et al.. (2005). Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma. Cancer Biology & Therapy. 4(3). 342–346. 99 indexed citations
8.
Tanaka, Tomoyuki, Peter DeLong, Kunjlata M. Amin, et al.. (2005). Treatment of Lung Cancer Using Clinically Relevant Oral Doses of the Cyclooxygenase-2 Inhibitor Rofecoxib. Annals of Surgery. 241(1). 168–178. 25 indexed citations
9.
Sterman, Daniel H., Anil Vachani, Jing Sun, et al.. (2005). Long-term Follow-up of Patients with Malignant Pleural Mesothelioma Receiving High-Dose Adenovirus Herpes Simplex Thymidine Kinase/Ganciclovir Suicide Gene Therapy. Clinical Cancer Research. 11(20). 7444–7453. 101 indexed citations
10.
Kruklitis, Robert, Sunil Singhal, Peter DeLong, et al.. (2004). Immuno-gene therapy with interferon-β before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma. Journal of Thoracic and Cardiovascular Surgery. 127(1). 123–130. 42 indexed citations
11.
Suzuki, Eiji, Veena Kapoor, Hung Kam Cheung, et al.. (2004). Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity. Clinical Cancer Research. 10(17). 5907–5918. 51 indexed citations
12.
Singhal, Sunil, Robert Kruklitis, Peter DeLong, et al.. (2003). Alterations in Cell Cycle Genes in Early Stage Lung Adenocarcinoma Identified by Expression Profiling. Cancer Biology & Therapy. 2(3). 291–298. 69 indexed citations
13.
Tliba, Omar, Samira Tliba, Chien‐Da Huang, et al.. (2003). Tumor Necrosis Factor α Modulates Airway Smooth Muscle Function via the Autocrine Action of Interferon β. Journal of Biological Chemistry. 278(50). 50615–50623. 65 indexed citations
14.
Singhal, Sunil, Kunjlata M. Amin, Robert Kruklitis, et al.. (2003). Differentially Expressed Apoptotic Genes in Early Stage Lung Adenocarcinoma Predicted by Expression Profiling. Cancer Biology & Therapy. 2(5). 566–571. 13 indexed citations
15.
DeLong, Peter, Tomoyuki Tanaka, Adam C. Henry, et al.. (2003). Use of cyclooxygenase-2 inhibition to enhance the efficacy of immunotherapy.. PubMed. 63(22). 7845–52. 77 indexed citations
16.
Odaka, Makoto, Rainer Wiewrodt, Peter DeLong, et al.. (2002). Analysis of the Immunologic Response Generated by Ad.IFN-β During Successful Intraperitoneal Tumor Gene Therapy. Molecular Therapy. 6(2). 210–218. 37 indexed citations
17.
DeLong, Peter & Robert M. Kotloff. (2000). An overview of pulmonary host defense. Seminars in Roentgenology. 35(2). 118–123. 5 indexed citations
18.
DeLong, Peter, et al.. (1999). Bacterial Lipopolysaccharide Induction of the Prostaglandin G/H Synthase 2 Gene Causes Thromboxane-Dependent Pulmonary Hypertension in Rabbits. American Journal of Respiratory Cell and Molecular Biology. 20(3). 493–499. 12 indexed citations
19.
Watanabe, Mamoru, D J Ringler, Morikazu Nakamura, Peter DeLong, & N L Letvin. (1990). Simian immunodeficiency virus inhibits bone marrow hematopoietic progenitor cell growth. Journal of Virology. 64(2). 656–663. 49 indexed citations
20.
Watanabe, Mamoru, et al.. (1989). Effect of recombinant soluble CD4 in rhesus monkeys infected with simian immunodeficiency virus of macaques. Nature. 337(6204). 267–270. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. J. Rinehart Breakdown of academic impact, for papers by Sherry T. Shu Breakdown of academic impact, for papers by Miriam Corti Breakdown of academic impact, for papers by Kohei Tada Breakdown of academic impact, for papers by Nobuyuki Uchida Breakdown of academic impact, for papers by Aaron R. Ellison Breakdown of academic impact, for papers by Sonja Thaler Breakdown of academic impact, for papers by Leal Oburoglu Breakdown of academic impact, for papers by Yonghua Zhuang Breakdown of academic impact, for papers by Douglas J. Dorahy
Rankless by CCL
2026